Observed Signal · Aug 19, 2026 · corporate_event · Source: SEC API · Impact: 3.2/5
8-K Financial Filing Analysis for Revolution Beauty (2026-08-19)
On August 17, 2026, the Compensation Committee of Revelation Biosciences, Inc. approved material restricted stock grants to executive leadership under its Amended and Restated 2021 Equity Incentive Plan. Chief Executive Officer James Rolke received 208,076 restricted shares, and Chief Financial Officer Chester S. Zygmont, III was granted 208,073 restricted shares. The equity awards are structured to vest across four equal 25% tranches linked to either reaching market capitalization hurdles of $30 million, $60 million, $90 million, and $120 million for 20 consecutive trading days, or time-based vesting at the two-year and four-year marks. The package aligns executive compensation with aggressive market valuation targets while providing retention security.
The executive equity grants establish explicit market valuation targets up to $120 million, directly incentivizing leadership to drive substantial shareholder value expansion and ensuring executive retention.
Track Revolution Beauty Signals & Market Shifts in Real-Time
Polaris7 autonomous intelligence agents track regulatory filings, primary sources, executive changes, and deal flow 24/7. Create your Polaris7 workspace to monitor these entities.
Key Takeaways & Evidence Grounding
- CEO James Rolke and CFO Chester S. Zygmont, III were granted 208,076 and 208,073 restricted shares, respectively, under the 2021 Equity Incentive Plan.
- Awards vest in four equal 25% tranches upon reaching market capitalization thresholds of $30M, $60M, $90M, and $120M sustained over 20 consecutive trading days, or alternatively at 2-year (first two tranches) and 4-year (final two tranches) time intervals.
- Grants include standard accelerated vesting protections upon a Change in Control or qualified involuntary termination events.
Connected Companies & Entities
1 Entity mappedRelated Market Signals & Shifts
Recent verified developments and strategic activity across this market segment.
8-K Financial Filing Analysis for Yext (2026-10-14)
On October 11, 2026, Yext, Inc. approved a long-term, performance-based stock option award granting CEO Michael Walrath the option to purchase 11,000,000 shares of common stock at an exercise price of $7.00 per share. The grant is intended as Walrath's sole equity compensation for the next ten years and is granted outside of the 2016 Equity Incentive Plan, making it contingent upon shareholder approval within twelve months. The award features zero time-based vesting, structured across 14 performance tranches with aggressive stock price hurdles ranging from $21.00 (3x current levels) up to $88.08 (over 12x current levels). Each hurdle requires meeting both 180-day and 30-day average closing price conditions, alongside post-achievement retention holding requirements, heavily aligning executive compensation with massive long-term shareholder value creation.
8-K Financial Filing Analysis for Houlihan Lokey (2026-09-22)
Houlihan Lokey reported several key governance and leadership actions following its annual stockholder meeting on September 16, 2026. Stockholders approved the Second Amended and Restated 2016 Incentive Award Plan, which sets the reserved share pool at 12 million shares, reinstates an annual evergreen replenishment at a reduced 1% rate (down from 6%), and eliminates the fixed plan expiration date. Additionally, the company announced the election of Thomas Reichert to the Board as an independent Class I director effective October 1, 2026, receiving a $120,000 initial restricted stock grant. In executive leadership changes, General Counsel Christopher M. Crain retired to transition into a Corporate Senior Advisor role, and Prabha Sipi Bhandari was appointed as Chief Legal Officer and Secretary.
8-K Financial Filing Analysis for Digital Turbine (2026-09-08)
On September 1, 2026, the Board of Directors and Compensation Committee of Digital Turbine, Inc. approved fiscal year 2027 long-term incentive awards (FY2027 LTI Awards) under its 2020 Equity Incentive Plan, with a grant date of September 2, 2026. The awards were granted to key named executive officers: CEO William Stone, CBO Michael Akkerman, Interim CFO/CAO Joshua Kinsell, and CTO Benneaser John. The awards are structured evenly with a 50/50 split between performance-based restricted stock units (PSUs) and time-based restricted stock units (RSUs). PSUs are tied equally to FY2028 and FY2029 Adjusted EBITDA targets and Relative TSR benchmarking against the S&P Software & Services Select Industry Index through June 15, 2029, with payouts ranging from 50% at threshold to 150% at maximum performance.
Receive all future signals for Revolution Beauty & competitors in your briefing
Never miss material M&A deals, leadership changes, account wins, or product rollouts. Polaris7 monitors 20,000+ primary sources 24/7, delivering verified telemetry directly into your executive briefing.